These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 2884081)

  • 1. The inhibitory effect of azelastine and ketotifen on histamine-induced bronchoconstriction in asthmatic patients.
    Magnussen H
    Chest; 1987 Jun; 91(6):855-8. PubMed ID: 2884081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of azelastine and ketotifen on the bronchial and skin responses to platelet-activating factor in humans.
    Lai CK; Ollier S; Lau CK; Holgate ST
    Clin Exp Allergy; 1991 Jul; 21(4):489-96. PubMed ID: 1680533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Duration of the effect of a single dose of azelastine on histamine-induced bronchoconstriction.
    Magnussen H; Reuss G; Jörres R; Aurich R
    J Allergy Clin Immunol; 1989 Feb; 83(2 Pt 1):467-71. PubMed ID: 2563744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The inhibitory effect of azelastine hydrochloride on histamine- and allergen-induced bronchoconstriction in atopic asthma.
    Rafferty P; Holgate ST
    Clin Exp Allergy; 1989 May; 19(3):315-20. PubMed ID: 2736431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of H1-receptor blockade on the development of early- and late-phase bronchoconstriction and increased bronchial responsiveness in allergen-induced asthma.
    Twentyman OP; Ollier S; Holgate ST
    J Allergy Clin Immunol; 1993 Jun; 91(6):1169-78. PubMed ID: 8099592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Azelastine in the prophylactic treatment of bronchial asthma: an Italian multicentre comparison with ketotifen.
    Ambrosi L; Bariffi F; Carino M; Catena E; Ceccarelli G; Ciampini M; Condoluci M; Crimi N; Ferretti G; Gambaro G
    J Int Med Res; 1989; 17(3):218-25. PubMed ID: 2569993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of azelastine on exercise-induced asthma.
    Magnussen H; Reuss G; Jörres R; Aurich R
    Chest; 1988 May; 93(5):937-40. PubMed ID: 2896104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of allergic histamine release by azelastine and selected antiallergic drugs from rabbit leukocytes.
    Chand N; Pillar J; Diamantis W; Sofia RD
    Int Arch Allergy Appl Immunol; 1985; 77(4):451-5. PubMed ID: 2410374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of azelastine on bronchoconstriction induced by histamine and leukotriene C4 in patients with extrinsic asthma.
    Albazzaz MK; Patel KR
    Thorax; 1988 Apr; 43(4):306-11. PubMed ID: 2900560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of calcium ionophore (A23187)-stimulated histamine release from rat peritoneal mast cells by azelastine: implications for its mode of action.
    Chand N; Pillar J; Diamantis W; Perhach JL; Sofia RD
    Eur J Pharmacol; 1983 Dec; 96(3-4):227-33. PubMed ID: 6202531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of cysteinyl-leukotriene production by azelastine and its biological significance.
    Achterrath-Tuckermann U; Simmet T; Luck W; Szelenyi I; Peskar BA
    Agents Actions; 1988 Jul; 24(3-4):217-23. PubMed ID: 2902760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose related protective effect of azelastine on histamine induced bronchoconstriction in extrinsic asthma.
    Bauer K; Aurich R; Kaik G
    Int J Clin Pharmacol Ther Toxicol; 1990 Aug; 28(8):333-8. PubMed ID: 1980266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition by azelastine of nonallergic histamine release from rat peritoneal mast cells.
    Fields DA; Pillar J; Diamantis W; Perhach JL; Sofia RD; Chand N
    J Allergy Clin Immunol; 1984 Mar; 73(3):400-3. PubMed ID: 6199399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study of the clinical efficacy of azelastine in patients with extrinsic asthma, and its effect on airway responsiveness.
    Gould CA; Ollier S; Aurich R; Davies RJ
    Br J Clin Pharmacol; 1988 Nov; 26(5):515-25. PubMed ID: 2905153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Azelastine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential.
    McTavish D; Sorkin EM
    Drugs; 1989 Nov; 38(5):778-800. PubMed ID: 2574665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of azelastine and some other antiasthmatic and antiallergic drugs on calmodulin and protein kinase C.
    Middleton E; Ferriola P; Drzewiecki G; Sofia RD
    Agents Actions; 1989 Aug; 28(1-2):9-15. PubMed ID: 2571246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of antihistamines and antiallergic drugs on responses to allergen and histamine provocation tests in asthma.
    Phillips MJ; Ollier S; Gould C; Davies RJ
    Thorax; 1984 May; 39(5):345-51. PubMed ID: 6429878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of passive cutaneous anaphylaxis (PCA) by azelastine: dissociation of its antiallergic activities from antihistaminic and antiserotonin properties.
    Chand N; Harrison JE; Rooney SM; Sofia RD; Diamantis W
    Int J Immunopharmacol; 1985; 7(6):833-8. PubMed ID: 3935586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The in vivo potency and selectivity of azelastine as an H1 histamine-receptor antagonist in human airways and skin.
    Rafferty P; Harrison PJ; Aurich R; Holgate ST
    J Allergy Clin Immunol; 1988 Dec; 82(6):1113-8. PubMed ID: 2904931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of IgE-mediated allergic histamine release from rat peritoneal mast cells by azelastine and selected antiallergic drugs.
    Chand N; Pillar J; Diamantis W; Sofia RD
    Agents Actions; 1985 Jul; 16(5):318-22. PubMed ID: 2413739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.